Many ongoing clinical trials on AD are focused on disease-modifying therapies (DMTs) that target the causes and can change the course of AD
In an ever-evolving market, biopharmaceutical manufacturers must consider the more direct role patients may play in defining value and even launch uptake
Persistent vomiting or diarrhoea, or the dizziness, headache and very dark urine of real dehydration, warrant a call to your prescriber
460 The biosynthesis of NAD + in adipocytes is crucial for the extension of HDF-induced white fat depots and may have more specific effects in lipid accumulation and processing
Various groups of patients can benefit from its use, whether as a monotherapy or in combination with other treatments
Gastrointestinal symptoms typically emerge during the initial weeks of treatment or following dose escalation, when the body is adjusting to increased medication levels